Body

“We decided it was high time such a meeting of minds was held in Europe, particularly when globalization of the pharmaceutical industry continues at a rapid pace, the European Union has expanded to 25 countries and with the increasing influence of India and China on the international regulatory and manufacturing environment,” says Paul D’Eramo, Johnson & Johnson USA executive director and chair of the ISPE board of directors.
…
Want to continue?
Log in or create a FREE account.
By logging in you agree to receive communication from Quality Digest.
Privacy Policy.
Add new comment